ArticleJournal for immunotherapy of cancer2024

Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.

Aryana M Razmara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.